Anastasia I Petra1, Smaro Panagiotidou1, Erifili Hatziagelaki2, Julia M Stewart1, Pio Conti3, Theoharis C Theoharides4. 1. Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts. 2. Second Department of Internal Medicine, Attikon General Hospital, Athens Medical School, Athens, Greece. 3. Department of Medical Sciences, Immunology Division, University of Chieti, Via dei Vestini, Chieti, Italy. 4. Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts; Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts; Department of Psychiatry, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts. Electronic address: theoharis.theoharides@tufts.edu.
Abstract
PURPOSE: Gut microbiota regulate intestinal function and health. However, mounting evidence indicates that they can also influence the immune and nervous systems and vice versa. This article reviews the bidirectional relationship between the gut microbiota and the brain, termed the microbiota-gut-brain (MGB) axis, and discusses how it contributes to the pathogenesis of certain disorders that may involve brain inflammation. METHODS: Articles were identified with a search of Medline (starting in 1980) by using the key words anxiety, attention-deficit hypersensitivity disorder (ADHD), autism, cytokines, depression, gut, hypothalamic-pituitary-adrenal (HPA) axis, inflammation, immune system, microbiota, nervous system, neurologic, neurotransmitters, neuroimmune conditions, psychiatric, and stress. FINDINGS: Various afferent or efferent pathways are involved in the MGB axis. Antibiotics, environmental and infectious agents, intestinal neurotransmitters/neuromodulators, sensory vagal fibers, cytokines, and essential metabolites all convey information to the central nervous system about the intestinal state. Conversely, the hypothalamic-pituitary-adrenal axis, the central nervous system regulatory areas of satiety, and neuropeptides released from sensory nerve fibers affect the gut microbiota composition directly or through nutrient availability. Such interactions seem to influence the pathogenesis of a number of disorders in which inflammation is implicated, such as mood disorder, autism-spectrum disorders, attention-deficit hypersensitivity disorder, multiple sclerosis, and obesity. IMPLICATIONS: Recognition of the relationship between the MGB axis and the neuroimmune systems provides a novel approach for better understanding and management of these disorders. Appropriate preventive measures early in life or corrective measures such as use of psychobiotics, fecal microbiota transplantation, and flavonoids are discussed.
PURPOSE: Gut microbiota regulate intestinal function and health. However, mounting evidence indicates that they can also influence the immune and nervous systems and vice versa. This article reviews the bidirectional relationship between the gut microbiota and the brain, termed the microbiota-gut-brain (MGB) axis, and discusses how it contributes to the pathogenesis of certain disorders that may involve brain inflammation. METHODS: Articles were identified with a search of Medline (starting in 1980) by using the key words anxiety, attention-deficithypersensitivity disorder (ADHD), autism, cytokines, depression, gut, hypothalamic-pituitary-adrenal (HPA) axis, inflammation, immune system, microbiota, nervous system, neurologic, neurotransmitters, neuroimmune conditions, psychiatric, and stress. FINDINGS: Various afferent or efferent pathways are involved in the MGB axis. Antibiotics, environmental and infectious agents, intestinal neurotransmitters/neuromodulators, sensory vagal fibers, cytokines, and essential metabolites all convey information to the central nervous system about the intestinal state. Conversely, the hypothalamic-pituitary-adrenal axis, the central nervous system regulatory areas of satiety, and neuropeptides released from sensory nerve fibers affect the gut microbiota composition directly or through nutrient availability. Such interactions seem to influence the pathogenesis of a number of disorders in which inflammation is implicated, such as mood disorder, autism-spectrum disorders, attention-deficithypersensitivity disorder, multiple sclerosis, and obesity. IMPLICATIONS: Recognition of the relationship between the MGB axis and the neuroimmune systems provides a novel approach for better understanding and management of these disorders. Appropriate preventive measures early in life or corrective measures such as use of psychobiotics, fecal microbiota transplantation, and flavonoids are discussed.
Authors: Marco Idzko; Elisabeth Panther; Christian Stratz; Tobias Müller; Hannes Bayer; Gernot Zissel; Thorsten Dürk; Stephan Sorichter; Francesco Di Virgilio; Michael Geissler; Bernd Fiebich; Yared Herouy; Peter Elsner; Johannes Norgauer; Davide Ferrari Journal: J Immunol Date: 2004-05-15 Impact factor: 5.422
Authors: Carlos Magno da Costa Maranduba; Sandra Bertelli Ribeiro De Castro; Gustavo Torres de Souza; Cristiano Rossato; Francisco Carlos da Guia; Maria Anete Santana Valente; João Vitor Paes Rettore; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Antônio Márcio Resende do Carmo; Gilson Costa Macedo; Fernando de Sá Silva Journal: J Immunol Res Date: 2015-02-22 Impact factor: 4.818
Authors: Irene Tsilioni; Harry Pantazopoulos; Pio Conti; Susan E Leeman; Theoharis C Theoharides Journal: Proc Natl Acad Sci U S A Date: 2020-06-29 Impact factor: 11.205
Authors: Jesseca A Paulsen; Travis S Ptacek; Stephen J Carter; Nianjun Liu; Ranjit Kumar; LaKeshia Hyndman; Elliot J Lefkowitz; Casey D Morrow; Laura Q Rogers Journal: Support Care Cancer Date: 2017-01-07 Impact factor: 3.603
Authors: Keith M Godfrey; Rebecca M Reynolds; Susan L Prescott; Moffat Nyirenda; Vincent W V Jaddoe; Johan G Eriksson; Birit F P Broekman Journal: Lancet Diabetes Endocrinol Date: 2016-10-12 Impact factor: 32.069